Treatment
Dihydroartemisinin Piperaquine clinical trials
We’re tracking 4 recruiting studies that include Dihydroartemisinin Piperaquine, each written for real people, not researchers, below.
Recruiting studies
- NCT05788094RecruitingPhase 4
Compare two medicines for P. vivax malaria
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
Mae Sot, Changwat TakAges 18 years+ - NCT06962319RecruitingPhase 3
Malaria treatment safety in early pregnancy
This trial tests how safe antimalarial drugs are during the first few months of pregnancy. It aims to find treatments that protect both mother and baby.
NanoroAges 16 years+ - NCT07389057Recruiting
Malaria prevention study with combined medicines in Ghana
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
Accra, Eastern RegionAges 3 months+ - NCT04704999RecruitingPhase 4
Testing the right tafenoquine dose for malaria prevention
This study tests the best dose of tafenoquine to treat people with symptoms from a malaria type called P. vivax and to help prevent it from coming back. You may be eligible if you recently had fever and meet specific blood and safety checks, especially G6PD level.
Siem ReapAges 2 years+
What Dihydroartemisinin Piperaquine is being studied for
Conditions with recruiting Dihydroartemisinin Piperaquine studies.
Common questions
- Are there clinical trials studying Dihydroartemisinin Piperaquine?
- Yes. Clin2 currently lists 4 recruiting studies that include Dihydroartemisinin Piperaquine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Dihydroartemisinin Piperaquine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Dihydroartemisinin Piperaquine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Dihydroartemisinin Piperaquine or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.